Literature DB >> 229241

Epstein-Barr virus DNA is amplified in transformed lymphocytes.

B Sugden, M Phelps, J Domoradzki.   

Abstract

Leukocytes isolated from two adult donors who lacked detectable antibodies to antigens associated with Epstein-Barr virus were exposed to an average of 0.02 to 0.1 DNA-containing particles of Epstein-Barr virus per cell and immediately clones in agarose. Within about 30 generations all transformed cell clones contained between 5 and 800 copies of viral DNA per cell. Only 1 in 10(4) to less than 1 in 10(5) of the cells of each clone release virus, and the frequency of release did not correlate with the average number of copies of viral DNA in the cells of each clone. One clone that had an average of five copies of viral DNA per cell was recloned, and the average number of copies in four of six subclones increased 15-to 50-fold while the subclones were being propagated sufficiently to study them. These results indicate that Epstein-Barr virus DNA can undergo amplification relative to cell DNA at different times after it transforms cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 229241      PMCID: PMC353487     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.

Authors:  J V PULVERTAFT
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

2.  DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr Virus.

Authors:  D Given; E Kieff
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

3.  Comparison of Epstein-Barr viral DNAs in Burkitt lymphoma biopsy cells and in cells clonally transformed in vitro.

Authors:  B Sugden
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

4.  The preparation of carrier-free iodine isotope-substituted cytosine nucleotides.

Authors:  N H Scherberg; S Refetoff
Journal:  Biochim Biophys Acta       Date:  1974-04-10

5.  Concentration of Epstein-Barr virus from cell culture fluids with polyethylene glycol.

Authors:  A Adams
Journal:  J Gen Virol       Date:  1973-09       Impact factor: 3.891

6.  Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells.

Authors:  M Nonoyama; J S Pagano
Journal:  Nat New Biol       Date:  1972-08-09

7.  Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies.

Authors:  T Lindahl; G Klein; B M Reedman; B Johansson; S Singh
Journal:  Int J Cancer       Date:  1974-06-15       Impact factor: 7.396

8.  Transformation of human leucocytes by throat washing from infectious mononucleosis patients.

Authors:  R S Chang; H D Golden
Journal:  Nature       Date:  1971-12-10       Impact factor: 49.962

9.  Clonal transformation of adult human leukocytes by Epstein-Barr virus.

Authors:  B Sugden; W Mark
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

10.  Human lymphoblastoid cell lines derived from individuals without lymphoproliferative disease contain the same latent forms of Epstein-Barr virus DNA as those found in tumor cells.

Authors:  C Kaschka-Dierich; L Falk; G Bjursell; A Adams; T Lindahl
Journal:  Int J Cancer       Date:  1977-08-15       Impact factor: 7.396

View more
  41 in total

1.  The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling.

Authors:  K D Erickson; J M Martin
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  B-cell lymphoproliferation and lymphomagenesis are associated with clonotypic intracellular terminal regions of the Epstein-Barr virus.

Authors:  N A Brown; C R Liu; Y F Wang; C R Garcia
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Presence of Epstein-Barr virus in esophageal cancer is restricted to tumor infiltrating lymphocytes.

Authors:  Sabine Awerkiew; Axel zur Hausen; Stephan E Baldus; Arnulf H Hölscher; Svetlana I Sidorenko; Sergej I Kutsev; Herbert J Pfister
Journal:  Med Microbiol Immunol       Date:  2005-02-04       Impact factor: 3.402

4.  EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA.

Authors:  Nara Lee; Walter N Moss; Therese A Yario; Joan A Steitz
Journal:  Cell       Date:  2015-02-05       Impact factor: 41.582

5.  The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA.

Authors:  E A Hurley; L D Klaman; S Agger; J B Lawrence; D A Thorley-Lawson
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

6.  Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells.

Authors:  J L Yates; N Guan
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

7.  Levels of Epstein-Barr virus DNA in lymphoblastoid cell lines are correlated with frequencies of spontaneous lytic growth but not with levels of expression of EBNA-1, EBNA-2, or latent membrane protein.

Authors:  S Metzenberg
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

8.  The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.

Authors:  J C Knutson
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

9.  The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells.

Authors:  L Sternås; T Middleton; B Sugden
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

10.  When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates.

Authors:  E A Hurley; S Agger; J A McNeil; J B Lawrence; A Calendar; G Lenoir; D A Thorley-Lawson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.